Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangmin Tong

Showing results (101-110 of 123) with videos related to

Pageof 13
Sort By:
Bioengineered|May 5, 2022
Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosisJing Yang, Yi Zhou, Yanchun Li, et al.
Journal of Colloid and Interface Science|May 27, 2024
Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancerJiaqing Huang, Lichen Ji, Jingxing Si, et al.
Biology Direct|January 15, 2025
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphomaQiangan Jing, Yunyi Wu, Yanchun Li, et al.
Journal of Nanobiotechnology|March 3, 2023
Recent advances of CREKA peptide-based nanoplatforms in biomedical applicationsNannan Zhang, Bin Ru, Jiaqi Hu, et al.
Free Radical Biology & Medicine|December 18, 2018
DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritinJing Du, Tongtong Wang, Yanchun Li, et al.
Redox Biology|November 19, 2025
Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell deathYajuan Lu, Yunyi Wu, Chen Yang, et al.
ACS Nano|June 24, 2024
Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer TherapyYuchan You, Luwen Zhu, Yanling Song, et al.
Cancer Letters|May 25, 2026
Repurposing the Neurokinin-1 Receptor Antagonist Aprepitant to Eradicate Relapsed/Refractory Acute Lymphoblastic Leukemia via Mitochondria-Driven NecroptosisGang Shao, Hanling Pan, Jiayi Zhu, et al.
Nature Cancer|April 18, 2025
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trialWen Lei, Hui Liu, Wenhai Deng, et al.
Acta Biochimica Et Biophysica Sinica|March 6, 2026
Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathwayYuhan Chen, Feiyan Pan, Lusheng Tang, et al.
Pageof 13

Showing results (101-110 of 123) with videos related to

Sort By:
Pageof 13
Bioengineered|May 5, 2022
Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosisJing Yang, Yi Zhou, Yanchun Li, et al.
Journal of Colloid and Interface Science|May 27, 2024
Platelet membrane-coated oncolytic vaccinia virus with indocyanine green for the second near-infrared imaging guided multi-modal therapy of colorectal cancerJiaqing Huang, Lichen Ji, Jingxing Si, et al.
Biology Direct|January 15, 2025
Bi-targeting of thioredoxin 1 and telomerase by thiotert promotes cell death of myelodysplastic syndromes and lymphomaQiangan Jing, Yunyi Wu, Yanchun Li, et al.
Journal of Nanobiotechnology|March 3, 2023
Recent advances of CREKA peptide-based nanoplatforms in biomedical applicationsNannan Zhang, Bin Ru, Jiaqi Hu, et al.
Free Radical Biology & Medicine|December 18, 2018
DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritinJing Du, Tongtong Wang, Yanchun Li, et al.
Redox Biology|November 19, 2025
Ferredoxins: master regulators in mitochondrial redox homeostasis and programmed cell deathYajuan Lu, Yunyi Wu, Chen Yang, et al.
ACS Nano|June 24, 2024
Self-Illuminating Nanoagonist Simultaneously Induces Dual Cell Death Pathways via Death Receptor Clustering for Cancer TherapyYuchan You, Luwen Zhu, Yanling Song, et al.
Cancer Letters|May 25, 2026
Repurposing the Neurokinin-1 Receptor Antagonist Aprepitant to Eradicate Relapsed/Refractory Acute Lymphoblastic Leukemia via Mitochondria-Driven NecroptosisGang Shao, Hanling Pan, Jiayi Zhu, et al.
Nature Cancer|April 18, 2025
Safety and feasibility of 4-1BB co-stimulated CD19-specific CAR-NK cell therapy in refractory/relapsed large B cell lymphoma: a phase 1 trialWen Lei, Hui Liu, Wenhai Deng, et al.
Acta Biochimica Et Biophysica Sinica|March 6, 2026
Lonidamine ameliorates MASH by reducing SREBP1 and inhibiting the MAPK pathwayYuhan Chen, Feiyan Pan, Lusheng Tang, et al.
Pageof 13